{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:17:14Z","timestamp":1770679034367,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Reports"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Concurrent chemoradiotherapy with high\u2010dose (HD) cisplatin is the standard treatment for locally advanced head and neck squamous cell carcinoma (LA\u2010HNSCC). Due to the higher treatment\u2010related adverse effects with standard therapy, alternative regimens (non\u2010standard therapy), namely, lower dose weekly cisplatin, carboplatin\/paclitaxel, or cetuximab are considered. There is, however, no consensus on non\u2010standard regimens. We aimed to investigate the efficacy and safety profile of these regimens.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This single centre retrospective cohort study included all consecutive adult patients with newly diagnosed LA\u2010HNSCC treated with either standard or non\u2010standard regimens between January 2016 and April 2021. The primary outcome was 2\u2010year failure\u2010free survival (FFS). The secondary outcomes included acute toxicities, hospitalisation rates, dose modifications, treatment failure rates (TFR), and overall survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>About 235 patients were included in the final analysis; median age was 61\u2009years (IQR 55\u201367), and 87% were male. Most had oropharyngeal tumours (85.5%) and p16\u2010positivity was frequent (80%). About 56% received non\u2010standard regimens: weekly cisplatin\u00a0=\u00a079 and non\u2010cisplatin\u00a0=\u00a048. These patients had higher Charlson Comorbidity Index (CCI; <jats:italic>p<\/jats:italic>\u00a0&lt;\u2009.001) and lower European Cooperative Oncology Group (ECOG)\u20100 (<jats:italic>p<\/jats:italic>\u00a0=\u2009.003). There was no difference in 2\u2010year FFS (hazard ratio [HR]\u00a0=\u00a01.16; 95% confidence interval \u2013 [CI] 0.65\u20132.05), hospitalisation and grade\u20103 toxicity rates between the two regimens. Nausea and vomiting were lower in the non\u2010standard regimen (3.0% vs. 16%, <jats:italic>p<\/jats:italic>\u00a0&lt;\u2009.001). Dose reductions, adjusted for age, sex, and CCI, were less likely in the non\u2010standard regimen (OR\u00a0=\u00a02.36; 95%\u2010CI: 1.01\u20135.49, <jats:italic>p<\/jats:italic>\u00a0=\u2009.007).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We demonstrated similar efficacy of lower dose weekly cisplatin and carboplatin\/paclitaxel regimens and better safety profile of weekly cisplatin compared to standard HD cisplatin regimens for LA\u2010HNSCC. Multicenter randomised control trials are required in HD cisplatin\u2010ineligible patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cnr2.1674","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T11:41:02Z","timestamp":1657107662000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment outcomes of standard (high dose) cisplatin and non\u2010standard chemotherapy for locally advanced head and neck cancer"],"prefix":"10.1002","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6443-2350","authenticated-orcid":false,"given":"Muhammad","family":"Alamgeer","sequence":"first","affiliation":[{"name":"Department of Medical Oncology Monash Health  Clayton Victoria Australia"},{"name":"Faculty of Medicine, Nursing and Health Sciences Monash University  Clayton Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Peter MacCallum Cancer Centre  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lachlan","family":"McDowell","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Peter MacCallum Cancer Centre  Parkville Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Giddings","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery Monash Health  Clayton Victoria Australia"},{"name":"Department of Surgery, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences Monash University  Clayton Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Safdar","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery Monash Health  Clayton Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Sigston","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Head and Neck Surgery Monash Health  Clayton Victoria Australia"},{"name":"Department of Surgery, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences Monash University  Clayton Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology Monash Health  Clayton Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Nursing and Health Sciences Monash University  Clayton Victoria Australia"},{"name":"Department of Intensive Care Medicine Peninsula Health  Frankston Victoria Australia"},{"name":"Peninsula Clinical School Monash University  Frankston Victoria Australia"},{"name":"Australian and New Zealand Intensive Care Research Centre (ANZIC\u2010RC), School of Public Health and Preventive Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.18.00219"},{"issue":"01","key":"e_1_2_9_3_1","first-page":"S48","article-title":"HPV \u2013 a different view on head and neck cancer","volume":"97","author":"Wittekindt C","year":"2018","journal-title":"Laryngorhinootologie"},{"issue":"9","key":"e_1_2_9_4_1","first-page":"616","article-title":"The new face of head and neck cancer: the HPV epidemic","volume":"29","author":"Lewis A","year":"2015","journal-title":"Oncology"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2018.11"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.04.049"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1715715"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28048"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.05.036"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.008"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032646"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031317"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053422"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32779-X"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32752-1"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.04.015"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.0129"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.8614"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21389"},{"key":"e_1_2_9_21_1","unstructured":"https:\/\/www.eviq.org.au\/medical-oncology\/head-and-neck\/definitive-chemoradiation"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2013.02.019"},{"key":"e_1_2_9_23_1","unstructured":"https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"issue":"3","key":"e_1_2_9_24_1","first-page":"14","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"81","author":"General Assembly of the World Medical A","year":"2014","journal-title":"J Am Coll Dent"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2017-0015"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9457"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.021"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.4280"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.00.1990"},{"key":"e_1_2_9_30_1","article-title":"Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA\u2010HNSCC): results of the GORTEC 2015\u201001 \u201cPembroRad\u201d randomized trial","author":"Xs YT","year":"2020","journal-title":"Annals of Oncology"},{"issue":"108","key":"e_1_2_9_31_1","first-page":"57","article-title":"Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patients","volume":"20","author":"Rivelli TG","year":"2015","journal-title":"Discov Med"}],"container-title":["Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.1674","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cnr2.1674","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.1674","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:59:40Z","timestamp":1692323980000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cnr2.1674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1002\/cnr2.1674"],"URL":"https:\/\/doi.org\/10.1002\/cnr2.1674","archive":["Portico"],"relation":{},"ISSN":["2573-8348","2573-8348"],"issn-type":[{"value":"2573-8348","type":"print"},{"value":"2573-8348","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"2022-02-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1674"}}